SRI and neoplasm: Cell death upon decrease in sorcin expression dovetails with the high levels of sorcin expression associated with multiple myeloma, lymphoma, breast cancer and other cancers, and with sorcin upregulation in Multi Drug Resistant (MDR) tumor cells which are resistant to apoptosis onset.